Clin2
NCT06533007Possibly a fitEnrolling by invitation

How PDE3B affects metabolism in healthy adults

Type 2 DiabetesCardiometabolic SyndromeCardiovascular Diseases

Part of Heart & circulation, Hormones & metabolism clinical trials.

This study looks at how a protein called PDE3B affects your body's metabolism (how it uses energy). It may help researchers understand weight and insulin resistance better, which could lead to new treatments.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
40 people
Ages
21 years to 75 years
Study type
Observational

Who can take part

  • You are between 21 and 75 years old.
  • You haven't had a large weight change (more than 5%) in the last 2 months.
  • You do not have type 2 diabetes or any major organ disease.
  • You have not had cancer in the last 5 years.
  • You haven't had weight-loss or stomach/intestine surgery (except gallbladder or appendix removal).
  • You are not currently smoking or using illegal drugs.
  • You are not pregnant or breastfeeding.
  • You can temporarily stop any medications that might interfere with the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07868601Recruiting
Lifestyle and metabolism study for overweight adults

This study looks at how different lifestyle factors and metabolism affect health in overweight adults. It may help researchers understand how to better tailor nutrition and lifestyle advice.

Potsdam, Potsdam-Rehbrücke
NCT05216042Recruiting
Study of genetics and heart/metabolic health in adults

This study looks at how genetic markers (DNA) relate to heart health and “metabolic” health (how your body manages sugar and fat). You may be asked to provide genetic samples and follow study health checks and protocols to help researchers understand who is at higher risk.

Birmingham, Alabama
NCT07398300Recruiting
How GIP and GLP-1 affect insulin and blood flow in the body

This study uses a special full-body PET scan to see how two natural hormones, GIP and GLP-1, affect how your body uses sugar and moves blood. It includes healthy volunteers and people with type 2 diabetes who are on metformin only.

Copenhagen
NCT05501483Recruiting
Study how fat differences may relate to type 2 diabetes

This study looks at differences in body fat to understand why some people develop type 2 diabetes. You may be asked for blood tests and health information to see if your diabetes risk and body fat patterns are linked.

Stockholm
NCT07682233Recruiting· Phase 2
Study on a mitochondrial target and blood sugar control

This study tests a medicine called XBD173 to see how it affects blood sugar by targeting a protein inside cells' mitochondria. It may help people without diabetes learn about new ways to regulate blood sugar.

London
NCT06923644Recruiting
Personalized nutrition plan to prevent metabolic disease

This study tests whether a personalized nutrition plan based on your unique metabolism can help prevent chronic metabolic diseases like type 2 diabetes. You will follow a tailored diet and have your health monitored over time.

Maastricht

Hear when a new Type 2 diabetes trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.